Anna Mero
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- biodegradable polymer synthesis and properties
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 10
- biodegradable polymer synthesis and properties 4
-
- Blood properties and coagulation 9
- Co-authors
- Francesco Maria Veronese (16 shared papers)Gianfranco Pasut (30 shared papers)Monica Campisi (5 shared papers)Barbara Spolaore (4 shared papers)Angelo Fontana (4 shared papers)Zhihao Fang (2 shared papers)Tacey X. Viegas (2 shared papers)Oddone Schiavon (7 shared papers)
- Journals
- Journal of Controlled Release (6 papers)Bioconjugate Chemistry (6 papers)Advanced Drug Delivery Reviews (1 paper)Current Drug Targets (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Anna Mero
37 papers receiving 3.0k citations
Anna Mero's Hit Papers
Peers
Comparison fields: 5 of 117
- Biomaterials 930
- Pharmaceutical Science 274
- Molecular Medicine 182
- Surfaces, Coatings and Films 223
- Biotechnology 202
Countries citing papers authored by Anna Mero
This map shows the geographic impact of Anna Mero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mero more than expected).
Fields of papers citing papers by Anna Mero
This network shows the impact of papers produced by Anna Mero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mero. The network helps show where Anna Mero may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Mero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Impact of PEGylation on Biological Therapies Hit paper breakdown → | 2008 | 867 |
| 2 | 2011 | 379 | |
| 3 | 2014 | 241 | |
| 4 | 2007 | 206 | |
| 5 | 2007 | 206 | |
| 6 | 2014 | 137 | |
| 7 | 2011 | 107 | |
| 8 | 2009 | 87 | |
| 9 | 2007 | 79 | |
| 10 | 2012 | 74 | |
| 11 | 2011 | 67 | |
| 12 | 2012 | 64 | |
| 13 | 2013 | 62 | |
| 14 | 2009 | 53 | |
| 15 | 2014 | 51 | |
| 16 | 2014 | 48 | |
| 17 | 2016 | 44 | |
| 18 | 2015 | 38 | |
| 19 | 2009 | 36 | |
| 20 | 2008 | 35 |
About Anna Mero
Anna Mero is a scholar working on Biomaterials, Pulmonary and Respiratory Medicine, Molecular Biology, Molecular Medicine and Polymers and Plastics, having authored 37 papers that have together received 3.1k indexed citations. Recurring topics across this work include Protein purification and stability (10 papers), Nanoparticle-Based Drug Delivery (10 papers), Blood properties and coagulation (9 papers), biodegradable polymer synthesis and properties (4 papers), RNA Interference and Gene Delivery (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Microbial Metabolites in Food Biotechnology (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Biomaterials (930 citations), Pharmaceutical Science (274 citations), Molecular Medicine (182 citations), Surfaces, Coatings and Films (223 citations) and Biotechnology (202 citations). Anna Mero has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Francesco Maria Veronese, Gianfranco Pasut, Monica Campisi, Barbara Spolaore, Angelo Fontana, Zhihao Fang, Tacey X. Viegas, Oddone Schiavon, Rebecca Weimer and Bekir Dizman. Their work appears in journals such as Journal of Controlled Release, Bioconjugate Chemistry, Advanced Drug Delivery Reviews, Current Drug Targets and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.